Introduction {#h0.0}
============

Almost all processes in eukaryotic cells are presumed to be spatiotemporally controlled, but only in recent years has subcellular organization been shown to be highly significant also for bacterial cells ([@B1]). The documentation of distinct distribution patterns for proteins, lipids, and even RNAs in bacterial cells suggests that spatial organization of macromolecules is a conserved phenomenon in all cell types ([@B2]). In rod-shaped bacteria, the poles, characterized by unique composition and topology, are emerging as specialized sites for a wide variety of cellular functions, ranging from chromosome segregation to signal transduction and virulence ([@B3], [@B4]). Although the cues that recruit most proteins to the poles are largely unknown, in few cases, certain properties of the poles were suggested as potential localization cues. Interaction with the anionic phospholipid cardiolipin, which is enriched in regions of cytoplasmic membrane near the poles and septa of growing *Escherichia coli* cells ([@B5]), has been suggested to account for polar localization of the osmosensory transporter ProP and the mechanosensitive channel MscS ([@B6], [@B7]). Strong negative curvature (concave), which characterizes the poles and the sites near the forming septum in dividing rod-shaped bacterial cells, has been suggested to be sensed by DivIVA, a membrane-binding protein that localizes to the septa and the poles in *Bacillus subtilis* cells ([@B8], [@B9]), and by MinD, a cell division protein that oscillates between the poles in *E. coli* ([@B10]). Notably, strong positive curvature (convex) was suggested to play a role in the localization of the SpoVM protein to the peripheral membrane of the forespore during sporulation of *B. subtilis* cells ([@B11]). On the other hand, the Tar receptors of the chemotaxis complex were suggested to localize by stochastic self-assembly of clusters ([@B12]).

A central signal transduction system that localizes to the poles in *E. coli* is the phosphoenolpyruvate-dependent phosphotransferase system (PTS), which governs hierarchal uptake of carbohydrates and adjusts cell metabolism accordingly. The PTS regulates global pathways, such as catabolite repression and inducer exclusion ([@B13]), and specialized pathways that enable sugar utilization ([@B14]) in Gram-negative and Gram-positive bacteria. It has recently been shown by our lab that the PTS is subjected to spatiotemporal regulation ([@B15]). Hence, the "control center" of the PTS, i.e., the general PTS proteins enzyme I (EI) and HPr, was shown to cluster mainly near the cell poles. Polar localization of each protein occurs independently, but HPr was shown to be released from the poles in an EI- and sugar-dependent manner.

The general PTS proteins were shown to also spatially regulate downstream auxiliary PTS components. Thus, BglG, a transcription factor that positively regulates transcription of the β-glucoside utilization operon (*bgl*) in *E. coli*, is sequestered near the membrane in an inactive form via interaction with the β-glucoside transporter, BglF ([@B16]); in the presence of β-glucosides, BglG is dephosphorylated by BglF and migrates to the cell poles, where it is activated by EI and HPr; consequently, the dimeric form of BglG is released to the cytoplasm, where it binds to the emerging *bgl* transcript and antiterminates transcription of the *bgl* operon ([@B15]). Similarly, LicT, a BglG homologue from *B. subtilis*, has recently been shown to be localized near the poles upon addition of β-glucosides to the medium ([@B17]). Spatiotemporal control of other transcription regulators by sugar permeases was also documented, i.e., repression of Mlc and MalT activity as positive regulators of glucose and maltose utilization genes in *E. coli* via interaction and membrane sequestration with the PTS glucose permease ([@B18]) and the maltose ABC transporter MalFGK~2~ ([@B19]), respectively, and activation of MtlR as a positive regulator of mannitol operon expression in *B. subtilis* via interaction with the mannitol permease ([@B20]). Hence, the distinctly localized PTS proteins, i.e., the general PTS at the poles and the sugar permeases at the cell circumference, control expression of the sugar utilization genes via a series of orchestrated spatial relocations of regulatory proteins. Still, the nature of the cues that recruit the general proteins to the poles and the spatiotemporal mechanisms that ensure efficient uptake of sugars by relocation of the other PTS components are currently unknown.

In this study, we set out to identify the cues that recruit the general PTS proteins to the poles of *E. coli* cells, focusing mainly on EI, which is steadily present in this microdomain. We show that the anionic lipid cardiolipin, which localizes preferentially to the poles, is not involved in recruiting EI. Components of the chemotaxis complex, which clusters at the poles, i.e., the monocyte chemoattractant protein (MCP) receptors and the CheA sensor, the latter previously shown to interact with EI, are also not involved in EI polar recruitment. Following inhibition of cell division, either by antibiotic treatment or by mutations that lead to the formation of filamentous cells with multiple chromosomes, EI was detected near the budding septum, whose maturation is inhibited. This localization pattern is not due to nucleoid occlusion, since the same pattern is observed after chromosome condensation. Furthermore, EI localization is not due to RNA targeting and localized translation, since the mRNA that codes for EI localizes to the cytoplasm rather than to the poles.

A clue to the rationale behind the PTS protein localization pattern was provided by imaging them in pole-lacking cells: in spherical *E. coli* cells, formed due to mutations in cytoskeletal proteins or in response to treatment with cytoskeleton-inhibiting antibiotics, EI still clustered into foci. Intriguingly, the foci localized near the budding site of the intracytoplasmic membrane-bound vesicles (IMVs), previously shown to form in such cells ([@B21]). These sites, like the poles, are strongly curved, and we show here that the membrane curvature sensor protein DivIVA from *B. subtilis* colocalizes with EI to these sites. The other polar PTS proteins, HPr and BglG, also colocalize with EI near the IMVs in spherical cells. In accord with the suggestion that the PTS proteins localize to sites of negative curvature, in a murein hydrolase *E. coli* mutant with unusual polar and septum architecture, EI localized mainly to the highly curved corners of the flat fused poles. Finally, we show that the native EI protein of *B. subtilis* also localizes to sites of negative curvature in *B. subtilis* and *E. coli* cells. Taken together, our results provide evidence that geometric cues play a role in the localization of the general PTS proteins and emphasize the importance of cell architecture in the regulation of metabolic systems.

RESULTS {#h1}
=======

Candidate system approach for identifying the PTS-polar localization machinery. {#h1.1}
-------------------------------------------------------------------------------

It has previously been shown by our lab that the general PTS proteins localize to the poles of *E. coli* cells ([@B15]). Using a functional fusion between the EI and the mCherry proteins ([@B15]), we observed EI at the poles regardless of the growth conditions. In an attempt to identify a cellular machinery that mediates polar localization of the PTS proteins, we examined the EI localization pattern in mutant *E. coli* cells that are impaired in machineries that were implicated in setting up cell polarity, i.e., those that mediate membrane composition, cell division, nucleoid occlusion, or localized translation. Before initiating this approach, we verified that our previous observation of EI-mCherry at the *E. coli* cell poles is not due to fluorescent protein-mediated clustering ([@B22]) by imaging EI fused to a highly monomeric derivative of green fluorescent protein (mGFP), which does not cause false localization patterns ([@B23]). The EI-mGFP fusion protein localized to the poles and to the division sites of *E. coli* cells, similarly to the EI-mCherry protein (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material).

First, we asked if the polarly localized phospholipid cardiolipin ([@B5], [@B24]), which recruits polar proteins like ProP and MscS, is involved in EI polar positioning. To answer this, we compared the pattern of EI-mCherry distribution in wild-type and in *cls* mutant *E. coli* cells. The *cls* mutant cells have only trace amounts of cardiolipin (CL) ([@B6]), as verified by staining them with the 10-*N*-nonyl acridine orange (NAO) dye that binds to anionic phospholipids, preferably to CL ([@B25]) (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). The results, presented in [Fig. 1](#fig1){ref-type="fig"}, clearly indicate that the substantial decrease in CL levels in the *cls* mutant cells did not affect the polar and septal localization of the EI-mCherry protein (compare [Fig. 1A and B](#fig1){ref-type="fig"}), implying that CL is not involved in EI localization.

![Polar localization of EI does not depend on cardiolipin and the chemotaxis complex. Images showing EI-mCherry distribution in WC3899 *E. coli* cells mutated in the cardiolipin synthase (cls) gene (A) compared to the parental W3899 *cls*^+^ strain (B) and in AW546 *∆cheA E. coli* cells deleted for the *cheA* gene (C) or in UU2612 *E. coli* cells deleted of all chemotaxis receptors (E) compared to their respective parental strains AW546 and RP437 (D and F, respectively). The mCherry fusion protein was observed by fluorescence microscopy (red), and the cells were observed with phase microscopy (gray). Also, overlays of the signals from the fluorescence and phase microscopy are shown (merge). Scale bar corresponds to 1 µm.](mbo0051316350001){#fig1}

The next candidate that we considered was the chemotaxis complex, whose spatiotemporal organization is reminiscent of that of the PTS ([@B4], [@B26]). Moreover, an interaction between CheA and EI, as well as cross talk between the two systems, has been reported ([@B27], [@B28]). Therefore, we tested the subcellular localization of EI-mCherry in nonchemotactic *cheA* mutant cells ([@B29]) and in cells that lack all chemoreceptors (ΔMCPs) ([@B29]). In both cases, polar localization of EI was not affected (compare [Fig. 1C to D and E to F](#fig1){ref-type="fig"}), suggesting that the polarly localized chemotaxis complex does not play a role in EI positioning.

The subsequent candidate whose involvement in PTS localization we explored was the cell division machinery. For this purpose, we examined the EI localization pattern in *E. coli* strains that are impaired in different stages of cell division. We found that in cells depleted for MinCDE or FtsQ, or in which FtsI was inhibited by cephalexin treatment, all growing as nonseptate filamentous cells, EI consistently localized to the poles, as well as to the budding nonmaturing division sites, detected after the addition of the membrane stain Mito Tracker Green (MTG) ([Fig. 2A to C](#fig2){ref-type="fig"}). Hence, EI localization does not depend on the key components of the cell division machinery.

![EI localizes to the budding site of the nonmature septum in filamentous nondividing cells. Fluorescence microscopy images showing EI-mCherry distribution (red) in PB114 *E. coli* cells carrying a Δ*minCDE* mutation (A), in MCQ1 *E. coli* cells carrying an *ftsQ1*^ts^ mutation that were grown in the restrictive temperature (B), and in MG1655 *E. coli* wild-type cells treated with cephalexin (C). Membrane staining was with MTG (green), and DNA staining was with DAPI (blue). Overlays of the fluorescent signals are also shown (merge). Scale bar corresponds to 1 µm.](mbo0051316350002){#fig2}

The following candidate that we tested was nucleoid occlusion (NO), a process that prevents Z ring assembly and septa formation at nucleoid-occupied places, which is also involved in localizing proteins to the DNA-free regions at the cell poles. To examine if NO mediates EI localization, we took advantage of the finding that blocking translation with antibiotics, e.g., chloramphenicol, causes nucleoid compaction ([@B30], [@B31]), leaving larger DNA-free regions and enabling proteins, whose polar localization is due to NO, to disperse throughout these regions. Hence, we examined the localization pattern of EI-mCherry in cells that have been treated with chloramphenicol. The results indicate that EI-mCherry still localized to foci near the poles and did not disperse throughout the space that had been created due to the compaction of the nucleoid (compare [Fig. 3A and B](#fig3){ref-type="fig"}, showing cells untreated and treated with chloramphenicol, respectively). An even more obvious result was obtained when EI-mCherry was imaged in filamentous *ftsZ84* mutant cells, grown at the restrictive temperature, which had been treated with chloramphenicol ([Fig. 3C](#fig3){ref-type="fig"}). As a control, we imaged cells expressing PopZ-YFP, which had previously been shown to localize to the poles due to NO ([@B32]). The results in [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material demonstrate that, in filamentous *ftsZ84* cells treated with the translation inhibitor kasugamycin, PopZ-YFP largely spreads in the nucleoid-free space (see [Fig. S3](#figS3){ref-type="supplementary-material"}). Hence, EI is not confined to the poles due to NO.

![Nucleoid occlusion and localized translation do not account for EI polar localization. (A to C) Images showing EI-mCherry distribution in MG1655Φ(*ptsI*-mCherry) wild-type *E. coli* cells untreated (A) or treated with 150 µg/ml chloramphenicol for 20 min (B) and in PAT84Φ(*ptsI*-mCherry) *ftsZ844*^ts^ mutant cells that were shifted to the nonpermissive temperature (42°C) and treated with 150 µg/ml chloramphenicol for 20 min. The cells were observed with phase microscopy (gray), the mCherry fusion protein was observed by fluorescence microscopy (red), and DNA staining was with DAPI (white). (D) Fluorescence microscopy images of cells expressing the MS2-GFP protein (green) and an EI-mCherry fusion (red), whose encoding RNA transcripts are tagged with six repeats of the MS2-binding sites. Overlays of the fluorescent signals in panels A to D are also shown (merge). The arrow indicates the pole region. The scale bar corresponds to 1 µm.](mbo0051316350003){#fig3}

RNA targeting and localized translation were the final candidates we examined for a possible role in PTS localization. A recent study from our lab provided evidence that bacterial mRNAs localize to the regions, where their protein products are required, in a translation-independent manner, suggesting that localized translation may exist in bacteria as a mechanism for protein localization ([@B33]). To examine the possibility that EI polar localization is due to localized translation, we aimed at imaging the *ptsI* mRNA and its encoded EI protein simultaneously. To this end, we fused the *ptsI* gene to mCherry, tagged the resulting *ptsI-*mCherry mRNA with six repeats of the MS2 coat protein binding sites, and coexpressed it with the MS2-GFP fusion protein ([@B34]). The results in [Fig. 3D](#fig3){ref-type="fig"} show that, whereas the EI-mCherry protein localized to foci near the cell pole, the RNA transcripts that encode this protein were distributed in the cytoplasm. Hence, localization of the *ptsI* mRNA and its encoded EI protein do not correlate, precluding the possibility that localized translation, due to mRNA targeting, is involved in EI polar localization.

The general PTS proteins localize to regions of strong negative curvature in spherical *E. coli* cells. {#h1.2}
-------------------------------------------------------------------------------------------------------

The rod shape of bacterial cells is maintained by several proteins, including the prokaryotic actin homolog MreB ([@B35]). Mutations in their encoding genes or antibiotics that affect the function of these proteins result in the conversion of the cells from rod shaped to spherical ([@B21]). MreBCD has also been implicated in polar localization of proteins ([@B36], [@B37]). To examine whether MreB is important for EI localization, we imaged EI-mCherry in cells in which the MreB cytoskeletal system has been disrupted either by treatment with the MreB inhibitor A22 or by the *mreBCD* mutation. The results in [Fig. 4A](#fig4){ref-type="fig"} show that EI-mCherry did not spread out in A22-treated spherical cells but was rather clustered into foci, mostly one focus per cell. In 79% of the cells (*n* = 451), the EI-mCherry focus was adjacent to the budding site of the intracytoplasmic membrane-bound vesicles (IMVs), previously shown to form in such cells due to an imbalance between membrane synthesis and the cell surface requirement ([@B21]). The IMVs can be observed by differential interference contrast (DIC) and MTG membrane staining and are typified by the sharp angles ("corners") created between them and the cell membrane on both their sides. Similar results were obtained in spherical *∆mreBCD* cells, expressing EI-mCherry from a plasmid ([Fig. 4B](#fig4){ref-type="fig"}), or in A22-treated cells, expressing EI-mCherry from the chromosome ([Fig. 4C](#fig4){ref-type="fig"}), ruling out the possibility that this pattern of localization was caused by the antibiotic treatment or by EI overexpression, respectively. Importantly, when the N-terminal domain of EI fused to mCherry (EI-N-mCherry), previously shown not to localize to the poles ([@B15]), was expressed in A22-treated spherical cells, the fusion protein was distributed throughout the cell rather than localizing near the IMVs ([Fig. 4D](#fig4){ref-type="fig"}). Together, these results indicate that there is a significant correlation between EI localization and the highly curved sites in spherical cells, suggesting that EI is recruited to sites of strong negative membrane curvature.

![Spatial distribution of EI, HPr, and BglG in spherical *E. coli* cells and their colocalization. (A to C) Images showing the following *E. coli* strains expressing EI-mCherry from a plasmid (A and B) or from the chromosome (C): A22-treated PA340 (A), PA340-678 Δ*mreBCD* (B), A22-treated MG1655Φ(*ptsI*-mCherry) (C). (D) Images of A22-treated MG1655 *E. coli* cells expressing EI-N-mCherry. (E and F) Images of MG1655 Δ*pts E. coli* cells expressing EI-mCherry together with either HPr-GFP (E) or BglG-GFP (F). The mCherry and GFP fusion proteins were observed by fluorescence microscopy (red and green, respectively), and the cells were observed with DIC (gray). Membrane staining was with MTG (green). Overlays of the fluorescent signals and DIC microscopy (A, C, and D) or of the fluorescent signals (E and F) are also shown (merge).](mbo0051316350004){#fig4}

Because inactivation of MreB affects not only cell shape but also other molecular processes that are spatially synchronized, we asked if disruption of the cell shape has an effect on the subcellular organization of the PTS as a system and on its ability to function. First, we examined the localization patterns of known EI interaction partners, HPr and BglG, previously shown to colocalize with it, in spherical cells. In wild-type rod-shaped *E. coli* cells, a functional fusion between the phosphor carrier small protein HPr and GFP was shown to colocalize with EI-mCherry at the poles under nonstimulatory conditions, i.e., in the absence of PTS sugars, although localization of the two proteins was not interdependent ([@B15]). To test whether a similar mechanism prevails in spherical cells, we observed the localization of EI-mCherry and HPr-GFP, expressed at comparable levels, in A22-treated ∆*pts* spherical cells. The results in [Fig. 4E](#fig4){ref-type="fig"} demonstrate that, except for a small fraction of HPr-GFP dispersed in the cytoplasm, the two-fluorescent proteins colocalize near the IMVs, suggesting that each of the general PTS proteins potentially recognizes the IMVs. Notably, we did not observe spherical cells in which the HPr-GFP and EI-mCherry foci localized differently near IMVs (*n* = 518). Next, we coexpressed the auxiliary PTS transcription factor BglG fused to GFP, which has previously been shown to colocalize with the general PTS proteins at the poles ([@B15]), together with EI-mCherry and observed the distribution of the two proteins in A22-treated ∆*pts* spherical cells. The results in [Fig. 4F](#fig4){ref-type="fig"} show that BglG-GFP and EI-mCherry colocalize, as in rod-shaped cells. Finally, we compared the rate of glucose uptake by rod-shaped and spherical *E. coli* cells; the latter shape formed as a result of A22 treatment or due to a deletion of the *mreBCD* gene. As shown in [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material, glucose uptake by spherical and rod-shaped cells was at comparable efficiencies, implying that the PTS system functions appropriately in spherical cells. Together, these results indicate that the changes in cell shape do not affect spatial arrangement of the PTS system, nor does it affect its ability to function. The general PTS proteins localize to negatively curved regions, be it the cell poles of rod-shaped cells or the IMV budding sites of spherical cells.

The *E. coli* EI protein colocalizes with the negative membrane curvature sensor DivIVA protein from *B. subtilis*. {#h1.3}
-------------------------------------------------------------------------------------------------------------------

The membrane-anchored protein DivIVA from *B. subtilis* was the first bacterial protein shown to sense negative membrane curvature. In *B. subtilis* cells, DivIVA localizes predominantly to the division septum and to a lesser extent to the poles. However, when expressed in *E. coli* cells, DivIVA localized primarily to the poles, compared to the septum ([@B38], [@B39]). The difference in DivIVA localization patterns between *B. subtilis* and *E. coli* is explained by the difference in septum formation during cell division in these two organisms, i.e., whereas division of *B. subtilis* cells results in areas of extreme concave curvature at the two points where the division septum meets the lateral edge of the cell, which are more negatively curved than the hemispherical poles, *E. coli* cell division is mediated by gradual constriction of the cell membrane, creating angles that are less negatively curved than the poles ([@B8], [@B39]). To test the hypothesis that EI is recruited to sites of strong negative curvature, we compared its localization pattern to that of DivIVA. To this end, we coexpressed EI-mCherry and DivIVA-GFP in rod-shaped as well as in spherical *E. coli* cells. In dividing rod-shaped cells, the two fluorescent proteins colocalized at the poles and near the forming septum, both showing the highest intensity at the poles ([Fig. 5A](#fig5){ref-type="fig"}). In A22-treated spherical *E. coli* cells, EI-mCherry and DivIVA-GFP colocalize near IMV budding sites, although, unlike EI, some DivIVA-GFP was spread out in the cell ([Fig. 5B](#fig5){ref-type="fig"}). To rule out the possibility that DivIVA spreading is due to competition with EI for negatively curved sites, we expressed DivIVA-GFP in ∆*pts E. coli* cells, which are deleted for the genes expressing EI and HPr. The results (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material) show that DivIVA-GFP distribution is similar in the presence and absence of EI, that is, it localizes mainly to foci, but also spreads out to a certain extent in the cytoplasm. Hence, EI and the negative membrane curvature sensor DivVIA exhibit the same localization patterns in spherical cells.

![The *E. coli* EI protein and the *B. subtilis* DivIVA and EI proteins show similar localization patterns. (A and B) Images showing the distribution pattern of the *E. coli* EI protein fused to mCherry and the *B. subtilis* DivIVA protein fused to GFP in wild-type *E. coli* cells untreated (A) or treated with A22 (B). (C) Images showing EI-mCherry in MHD63, a murein hydrolase *E. coli* mutant. (D and E) Images showing the distribution pattern of the *B. subtilis* EI protein fused to GFP in wild-type *B. subtilis* (Bs) cells (D) and in ∆*pts E. coli* (Ec) cells (E). The cells were observed with phase microscopy or DIC (gray), and the mCherry and GFP fusion proteins were observed by fluorescence microscopy (red and green, respectively). Overlays of the fluorescent signals in panels A to C are also shown (merge). Arrows indicate negatively curved regions. The scale bar corresponds to 1 µm.](mbo0051316350005){#fig5}

Next, we examined EI localization in murein hydrolase *E. coli* mutant cells, which cannot separate after division, thus forming long chains of cells divided by relatively flat septa, reminiscent of *B. subtilis* cell chains ([@B40]). When the *B. subtilis* DivIVA protein was expressed in this *E. coli* mutant, it was observed mainly at the corners formed between the flat septa and the lateral cell membrane ([@B39]). When EI-mCherry was expressed in this mutant, it localized mainly to one of the highly curved corners of the flat fused poles ([Fig. 5C](#fig5){ref-type="fig"}). The difference in the average number of foci formed by the two proteins per cell is discussed below. Based on the results in [Fig. 5](#fig5){ref-type="fig"}, we conclude that the soluble EI protein, like the membrane-anchored DivIVA protein, is recruited to strongly curved subcellular sites.

Membrane curvature-mediated localization of EI is conserved across species. {#h1.4}
---------------------------------------------------------------------------

The major PTS protein EI is a widely conserved protein in both Gram-positive and Gram-negative bacteria. To understand if negative curvature-mediated localization is a conserved property of EI, we examined the localization of the *B. subtilis* EI protein, which shares a significant homology with the *E. coli* EI. For this purpose, we tagged the *B. subtilis* EI protein with GFP at its N terminus and introduced it into the *amyE* site in the *B. subtilis* chromosome. The resulting EI-GFP fusion protein, expressed from a xylose-inducible promoter, was functional and could complement a *∆ptsI B. subtilis* strain grown in minimal medium containing a PTS sugar as a sole carbon source, provided that xylose was added. When expressed in rich medium, such as LB, EI-GFP was distributed throughout the cell (data not shown). However, when expressed in cells grown in C medium supplemented with mannitol as a sole carbon source, EI-GFP localized in a pattern which is very similar to that reported for DivIVA, i.e., in nondividing *B. subtilis* cells, EI-GFP localized mainly to the cell pole, whereas in dividing cells it was detected as two bright spots near the forming septum and a weaker spot at the pole ([Fig. 5D](#fig5){ref-type="fig"}). Furthermore, when the *B. subtilis* EI-GFP protein was expressed in ∆*pts E. coli* cells, i.e., cells lacking the endogenous general PTS proteins, it localized near the cell pole in 41% of the cells (*n* = 412) ([Fig. 5E](#fig5){ref-type="fig"}). Of note, the *B. subtilis* EI-GFP protein can complement an *E. coli* strain with a mutation in the *ptsI* gene (see [Fig. S6](#figS6){ref-type="supplementary-material"}), in agreement with the ability of the *B. subtilis* EI to substitute for the *E. coli* EI *in vitro* ([@B41]). Taken together, we conclude that localization of EI to sites of strong negative curvature is a conserved property of this protein.

DISCUSSION {#h2}
==========

Molecular processes are often confined to subcellular compartments, thus circumventing the problem of intracellular molecular crowding ([@B42], [@B43]). Even in the absence of membrane barriers, many soluble enzymes that carry out distinct processes are integral parts of macromolecular assemblies, in both prokaryotic and eukaryotic cells ([@B44], [@B45]). The composition of macromolecular assemblies is dynamic, as certain components may participate in forming various assemblies at different subcellular regions or move between them, depending on environmental conditions. Such assemblies appear to have particular significance in compartmentalizing and regulating metabolic pathways ([@B46], [@B47]). There are obvious advantages to bringing together sequentially acting enzymes of specific metabolic pathways, as exemplified by the bacterial microcompartments (BMCs) that encapsulate metabolic reactions within a proteinaceous shell, thus enhancing catalytic activity, protecting vulnerable enzymes from degradation, and sequestering toxic intermediates ([@B48]). It is reasonable to assume that organizing signaling systems that respond to metabolites in macromolecular assemblies increases the efficiency of pathway flux and helps in generating optimal responses to environmental cues.

The poles of rod-shaped bacteria are emerging as important subdomains to which various molecular assemblies, which sense metabolites and adjust cell metabolism and behavior accordingly, localize. Examples include the chemotaxis complex in *E. coli* ([@B49], [@B50]) and in *Caulobacter crescentus* ([@B51]), the flagellum-dependent motility system in *Vibrio*, *Pseudomonas*, *Helicobacter*, and *Campylobacter* species, the flagellum-independent gliding motility in *Myxococcus xanthus* ([@B52]), and the control center of the PTS system in *E. coli*, which plays a central role in controlling the metabolic state in most bacterial cells depending on carbohydrate availability ([@B15]). Except for the PTS, all other polarly localized signaling systems have a membrane-anchored component(s). The PTS proteins known to localize to the poles are all soluble. They include EI, which remains at the poles independent of environmental conditions, HPr, which discharges from the poles in response to the presence of PTS sugars in the growth medium, and transcription factors that regulate PTS operons, i.e., BglG in *E. coli* and LicT in *B. subtilis*, which are recruited to the poles depending on the availability of sugars that are transported and metabolized by the products of the operons that they regulate ([@B15], [@B17]). The membrane-bound components of the PTS, the sugar permeases, do not localize specifically to the poles; rather, they are distributed around the cell circumference ([@B15], [@B16]). Hence, identifying the cues that recruit the soluble PTS proteins to the poles is important not only to improve our understanding of this central system, which has important implications on most other cellular pathways, but also to reveal fundamental mechanisms underlying organization and regulation of soluble systems in the bacterial cell.

To identify the cues that recruit the PTS proteins to the poles, we monitored the distribution pattern of the PTS proteins in cells in which known factors that set up cell polarity or that are tightly linked to it were systematically disrupted. We focused mainly, although not only, on EI, whose distribution pattern does not change much over time, and environmental conditions. We could thus show that EI localization does not depend on interaction with the phospholipid cardiolipin. Of note, proteins shown thus far to localize to the poles in a cardiolipin-dependent manner were integral membrane proteins and, hence, were more likely to interact with a phospholipid than the soluble EI protein. We also ruled out the possibility that the polar chemotaxis complex is required for recruiting EI to the poles, although the opposite scenario, i.e., that the PTS affects the organization of the chemotaxis complex, remains open. Because cell polarization and cell division are highly interrelated processes that regulate one another in a spatiotemporal manner ([@B53]) and because the cell poles are derived from the division septum, we could not rule out the possibility that the cell division machinery provides a mechanistic basis for the positioning of proteins at the poles. Indeed, birth scar proteins, formed at the division site that later establish polarity, have been reported in *C*. *crescentus* ([@B54], [@B55]). Still, despite the detection of EI near the forming septum in dividing cells, our results rule out the possibility that the cell division machinery is involved in recruiting EI to the poles. Additionally, we show that localization of EI to the poles is not due to nucleoid occlusion, since EI consistently localized to the poles of nucleoid-compacted cells, rather than spreading out in the nucleoid-free space, as observed for PopZ. Notably, the bacterial chromosome is not arbitrarily arranged and packaged, and certain regions are always positioned near the poles ([@B56]). Thus, the visualization of EI foci near the poles of nucleoid-compacted cells also precludes the possibility that EI interacts with a pole-proximal region in the bacterial chromosome or with certain proteins that direct this chromosomal region to the poles.

Targeting of mRNAs to the site where their protein products are required to enable localized translation is a well-established mechanism of protein localization in eukaryotic cells ([@B57], [@B58]). Until recently, it was believed that localization of bacterial proteins depends solely on features within the proteins and, hence, occurs either co- or posttranslationally ([@B1]). Recently, the possibility that bacterial proteins can be localized via mRNA targeting and localized translation, similarly to higher-order cells, has been suggested ([@B33]). Based on the results presented here, this is not the case for EI, since its encoding mRNA is spread in a typical distribution pattern visualized with cytoplasmic RNAs (see reference 33), whereas the protein itself is clearly observed near the poles. This result supports our previous suggestion that, similar to eukaryotic cells, certain mRNAs in bacteria localize to the future destination of their encoded proteins, whereas others do not ([@B2]), implying that enzymes like EI localize after being translated.

The nature of the cues that affect EI localization was unveiled when we visualized EI in *E. coli* cells that lost the ability to form a rod shape and are supposedly poleless. Notably, such so-called spherical cells, obtained by the disruption of the cytoskeletal or cell wall synthetic machineries via mutations or antibiotic treatments, do not occupy a perfect sphere shape. Rather, due to the imbalance between membrane synthesis and cell surface requirements, the cells produce phospholipid membrane in excess, leading to the formation of IMVs ([@B21]). The regions where the lateral cell membrane meets these protruding membrane involutions represent sites of high negative curvature, thus bearing geometric resemblance to the poles of rod-shaped cells. The IMVs were shown to be implicated in the localization of cell division proteins, including MinD ([@B21]), which oscillates between the poles of rod-shaped cells and has been suggested to sense curved regions ([@B10]). In light of all this information, our observation that EI localizes next to the IMV budding sites in spherical *E. coli* cells suggests that EI is recruited to sites of negative membrane curvature.

This hypothesis is reinforced by our observation that DivIVA, a negative membrane curvature sensor protein from *B. subtilis*, colocalizes with EI next to the IMVs in spherical *E. coli* cells. DivIVA emerges as a useful marker for tracking membrane organization *in vivo*, since a recent study also used DivIVA-GFP to detect sharply bent membrane regions in antibiotic-treated cells ([@B59]). The use of DivIVA-GFP as a "molecular sensor" for membrane curvature not only validates that the regions next to the IMVs are negatively curved, but it also is helpful in identifying regions of negative curvature when IMVs are not readily resolvable by DIC. Consistent with our assumption about the role of geometric cues in EI localization, in dividing rod-shaped *E. coli* cells, EI-mCherry and DivIVA-GFP formed less intense foci near the forming division septum (less curved regions) and a more intense foci near the poles (more curved regions). Still, DivIVA and EI differed in their localization patterns in a murein hydrolase *E. coli* mutant, which forms long chains of cells divided by rather flat septa; that is, whereas DivIVA was observed mainly in both negatively curved sites formed between the flat septa and the lateral cell membrane ([@B39]), EI-mCherry was observed mainly in one such site per cell. This difference might reflect differences in the oligomeric state and higher-order structure of the two proteins. Alternatively, it might be due to differences in their interacting partners, since DivIVA is bound to the membrane, whereas the soluble EI protein is probably associated with factors that maintain it at the poles.

The finding of Bendezu and de Boer that the sites in which MinD accumulates and between which it oscillates invariably coincide with the sites of IMV presence in spherical *E. coli* cells ([@B21]) raises the question of whether the IMV budding sites bear functional, and not only geometric, resemblance to the poles of rod-shaped cells. The results presented herein support this notion; not only are the known PTS interaction partners, HPr and BglG, colocalized with EI to these sites, but the kinetics of sugar uptake by spherical cells and normal rods are comparable. In light of our observations and previously published data, we propose that the IMV budding sites in poleless spherical *E. coli* cells represent pole-like regions, which maintain not only the geometric but also the functional features of the poles.

Recruitment to regions of high negative curvature seems to be a feature of the general PTS proteins which is conserved across species. Thus, when EI from *B. subtilis* was expressed in *E. coli* cells, it localized to the poles, which are the sites of highest negative curvature in these cells, similarly to the localization preference of the endogenous *E. coli* EI protein. When the same protein was expressed in *B. subtilis* cells, it localized preferentially to the two points where the division septum meets the lateral edge of the cell, which are the sites of highest negative curvature in these cells, but in the absence of forming septum, it localized to the cell pole. Still, one difference between the two organisms is that in *E. coli* cells, the EI proteins from both species localize to the cell pole independent of growth conditions, whereas in *B. subtilis* cells, EI localization seems to depend on growth conditions. Thus, when grown in LB, the native *B. subtilis* EI showed very little if any distinct localization (data not shown), similar to the distribution documented previously ([@B17]). The reason for the dependence of the *B. subtilis* EI localization pattern on the medium, which is in contrast to the lack of such dependence for *E. coli* EI ([@B15]), is currently not known. Since our results suggest that in addition to membrane curvature, more factors are involved in localizing EI to the poles (see below), it is likely that there are differences between EI pole-tethering factors in the two organisms.

The few proteins suggested thus far to be recruited to negatively curved regions contain a membrane-tethering component ([@B8]). The mechanisms that tether soluble proteins to the poles are less known. It has been suggested that PopZ in *Caulobacter* relies on multimerization in chromosome-free regions ([@B32], [@B60], [@B61]), but this does not seem applicable for EI and HPr, which have never been suggested to multimerize beyond dimers. The question then arises: does EI have other properties that direct it to the membrane, or does it localize via a partner that tethers it to curved membrane regions? To discern between these possibilities, we compared the EI localization pattern when expressed at a physiological level and when overexpressed from a plasmid in an *E. coli* Δpts strain. In the first case, EI was detected only as a spot ([Fig. 4C](#fig4){ref-type="fig"}), whereas in the second case, EI was detected as a rather large focus with the excess spreading out in the cytoplasm (see [Fig. S5B](#figS5){ref-type="supplementary-material"} in the supplemental material). These observations exclude the possibility that EI is able to recognize the membrane by itself, since in such a case we would expect to detect foci in other curved membrane locations upon overexpression rather than spread out in the cytoplasm, and suggest that other factors are involved in anchoring it to curved regions. What are these factors? The gap between the growing knowledge on bacterial macromolecular assemblies and the limited knowledge on the mechanisms that underlie their association led to the suggestion that bacterial cells have various kinds of structuring proteins, often associated with or penetrating into the cytoplasmic membrane ([@B62]). We speculate that this group includes proteins that sense membrane curvature and provide the bacterial cells with means to sort and position soluble proteins in highly curved regions.

The implications of cellular architecture on metabolic regulation. {#h2.1}
------------------------------------------------------------------

Undoubtedly, cell shape influences many processes, including cell survival and growth ([@B63]). Under routine laboratory growth conditions, changes in cell shape are not commonly observed. However, under conditions of environmental insults, including oxygen limitation, the presence of antibiotics, growth under competition, or intracellular growth in host cells, bacteria many times undergo changes in cell shape, including formation of spherical and filamentous cells ([@B64], [@B65]). Changes in cell shape often correlate with changes in localization of the cell division and cytoskeletal proteins ([@B21], [@B66]), ultimately resulting in a decrease or cessation of cell division. Under such unfavorable conditions, the cell division proteins are maintained in a nonfunctional state, rather than being degraded, making them available for the resumption of cell division when favorable environmental conditions are restored ([@B66], [@B67]). Negative regulation of protein activity by transient storage at the poles and relocation into the active pool upon requirement has been reported for MurG, an enzyme involved in cell wall biosynthesis ([@B68]). Our study suggests that cellular architecture is also involved in the regulation of major metabolic systems in bacteria, such as the PTS. However, unlike the cell division and cell wall biosynthesis proteins, changes in cellular morphology correlate with localization of the PTS proteins to subcellular domains that maintain their activity.

Combining the previously published data with the results reported here, we propose that changes in cell physiology induce dynamic survival strategies that involve reorganization of central cellular systems and, possibly, changes in cell morphology. However, whereas the cell division proteins are temporarily stored in an inactive form, thus saving the limited energy of the cells for processes essential for survival, the PTS and potentially other metabolic systems localize to subcellular domains, where they are active in sensing the environmental conditions and in the uptake of available nutrients, thus maintaining both cell viability and metabolic alertness. Upon encounter with favorable conditions, changes in cell morphology correlate with relocation of the cell division and metabolic machineries and reestablishment of normal cellular architecture. Our model hypothesizes that relocations of central cellular systems will be discovered in the future in organisms that undergo a reversible switch between rods and cocci upon encounter of unfavorable conditions, e.g., *Paenibacillus dendritiformis* ([@B69]). All together, we suggest that spatial regulation of central systems, including metabolic machineries, not only maintains optimal cell growth under favorable conditions but also provides a novel survival strategy that helps bacteria cope with certain unfavorable conditions.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and growth media. {#h3.1}
-----------------------------------

Bacterial strains used in this study are listed in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material. Unless otherwise indicated, cells were grown in LB at 30°C. PAT84Φ(*ptsI*-mCherry), expressing an EI-mCherry chromosomal fusion in an *ftsZ844*^ts^ mutant background, was constructed by transferring *ptsI*-mCherry from MG1655Φ(*ptsI*-mCherry) to the chromosome of PAT84 by P1 transduction, as described before ([@B70]). YE101, a *B. subtilis* strain that expressed an EI-GFP fusion from its chromosome, was constructed by integrating the pEA18-EI-GFP plasmid into the chromosome of GR39, a ∆*ptsI B. subtilis* strain obtained by transforming chromosomal DNA of GR26 ([@B71]), at the *amyE* locus, as described before ([@B72]). When appropriate, antibiotics were added at the following concentrations: 30 µg/ml kanamycin, 100 µg/ml ampicillin, and 25 µg/ml chloramphenicol for *E. coli* strains and 100 µg/ml spectinomycin and 6 µg/ml chloramphenicol for *B. subtilis* strains.

Plasmids. {#h3.2}
---------

Construction of pBADLLEI-mCherry, which encodes translational fusion of EI to mCherry, pBADANSEI-mCherry&HPr-GFP, which encodes both EI-mCherry and HPr-GFP from the same promoter, and pJS185, which encodes GFP fused to BglG, has been described before ([@B15]). pBADGSEI-mGFP, which expresses EI fused to monomeric GFP, was constructed by replacing the mCherry-encoding sequence with mGFP as follows: mGFP, which carries an A206K substitution in the GFPmut2 sequence, was amplified by PCR from plasmid pAR100 ([@B73]) using forward and reverse primers that introduced SacI and XbaI sites, respectively; the amplified DNA was ligated to the pBADLLEI-mCherry plasmid, which was digested with SacI and XbaI. Construction of pGSDivIVA-GFP, which encodes DivIVA fused with GFP, was carried out in two steps. First, the GFP-encoding sequence was amplified by PCR from pBADANSEI-mCherry&HPr-GFP with primers that introduced SalI (forward) and HindIII (reverse) sites and inserted into pQE32 (Qiagene), which was digested with SalI and HindIII, to generate pGS^lac^GFP. Second, the *divIVA* gene was amplified from *B. subtilis* PY79 genomic DNA, using primers that introduced SacI (forward) and SalI (reverse) sites and a sequence encoding a three alanine linker, and the resulting amplicon was ligated to pGS^lac^GFP, digested with SacI and SalI.

Construction of pGSbsEI-GFP, which encodes EI from *B. subtilis* fused with GFP, was carried out by amplifying the *ptsI* gene from the chromosome of the *B. subtilis* PY79 strain, using BamHI forward and SalI reverse primers, and ligating the resultant amplicon to the pGS^lac^GFP plasmid, digested with the same enzymes. pZE12EImCherry6xbs was constructed by amplifying EI-mCherry along with its ribosome binding site (RBS) from pBADLLEI-mCherry with primers that introduced BglII and EagII sites. The fragment was ligated to pZE126xbs ([@B46]), which was cleaved by the same enzymes. pEA18-*gfp-ptsI* was constructed by amplifying the *ptsI* gene from *B. subtilis* PY79 genomic DNA, using forward and reverse primers that introduced NotI and BamHI sites, respectively, and the resultant amplicon was ligated to pEA18 ([@B74]), digested with NotI and BamHI.

Fluorescence microscopy. {#h3.3}
------------------------

Cells, supplemented with the appropriate antibiotics, were grown in LB medium at 30°C till mid-log phase. To obtain spherical *E. coli* cells, A22 (2 µg/ml) was added from the beginning of the growth. For obtaining filamentous cells, cephalexin (20 µM) was added from the beginning of the growth. To induce nucleoid compaction, cells were treated with chloramphenicol (150 µg/ml) or kasugamycin (300 µg/ml) for 20 min. To express EI-mCherry, HPr-GFP, and EI-mGFP from the pBAD promoter, 0.1% arabinose was added at an optical density at 600 nm (OD~600~) of 0.3 for 1 h for rod-shaped cells and for 10 to 20 min in spherical cells. To express BglG-GFP and DivIVA-GFP, 0.1 mM and 1 mM IPTG (isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside) were added for 1 h, respectively. *B. subtilis* cells expressing a chromosomally integrated EI-GFP were grown in C medium supplemented with 1% mannitol till an OD~600~ of 0.4. Expression of the EI-GFP fusion protein was induced in these cells by adding 0.01% xylose from the beginning of growth. To express the *B. subtilis* EI protein fused to GFP from pGSbsEI-GFP in *E. coli* cells, 1 mM IPTG was added for 1 to 2 h after cells reached an OD~600~ of 0.3.

Fluorescence microscopy was carried out as described previously ([@B75]). In brief, 0.5 ml of cells was centrifuged, washed with 1× phosphate-buffered saline (PBS), and finally resuspended in 10 µl of PBS. When indicated, the membrane was stained with MTG (Molecular Probes, Invitrogen) at a final concentration of 10 µM, and DNA was stained with DAPI (4′,6-diamidino-2-phenylindole; Sigma) at a final concentration of 2 µg/ml. For cardiolipin staining, cells were washed and resuspended in 1× PBS that contained 100 nM nonyl acridine orange (NAO) and incubated at 37°C for 15 min. Cells were visualized and photographed using an Axioplan2 microscope (Zeiss) equipped with a CoolSnap HQ camera (Photometrics, Roper Scientific), Axiovert 200 M (Zeiss) equipped with a CoolSnap HQ camera (Photometrics, Roper Scientific), or Nikon Eclipse Ti equipped with an ORCA R2 camera (Hamamatsu Photonics). Images were processed using Metamorph Software (Molecular Devices).

Glucose consumption assay. {#h3.4}
--------------------------

Wild-type, A22-treated wild-type (2 µg/ml), ∆*mreBCD*, and ∆*pts* cells were grown in LB supplemented with 25 mM glucose, and the measurements of glucose consumption were performed as described before ([@B76]).

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

EI fused to monomeric GFP localizes to the *E. coli* cell poles. DIC and fluorescence microscopy images of *E. coli* cells expressing EI-mGFP and an overlay of the signals (green, gray, and merge, respectively). The scale bar corresponds to 1 µm. Download
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Figure S1, TIF file, 0.1 MB

###### 

Cardiolipin staining in *cls* mutant and wild-type cells. *E. coli* cells mutated in the cardiolipin synthase (*cls*) gene (A) and the parental *cls*^*+*^ strain (B) were stained with NAO (10-*N*-nonyl acridine orange), which binds to anionic lipids, preferably to CL. NAO was observed by fluorescence microscopy (green), and the cells were observed with phase microscopy (gray). Overlays of the signals are also shown (merge). The scale bar corresponds to 1 µm. Download
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Figure S2, TIF file, 0.3 MB
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Localization of PopZ in nucleoid-compacted cells. Images showing PopZ-YFP in PAT84 *ftsZ844*^ts^ mutant cells that were shifted to the nonpermissive temperature (42°C) and treated with 300 µg/ml kasugamycin for 20 min. The cells were observed with DIC microscopy (gray), the YFP fusion protein was observed by fluorescence microscopy (green), and DNA staining was with DAPI (white). An overlay of the fluorescent signals is also shown (merge). An arrow indicates the nucleoid-free region in a nucleoid-compacted cell. An asterisk indicates the pole region in a cell in which the nucleoid has not been compacted. Download
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Figure S3, TIF file, 0.1 MB

###### 

Glucose consumption by rod-shaped and spherical *E. coli* cells. MG1655 *E. coli* cells (wild type), untreated (blue) or treated with A22 (red), Δ*mreBCD E. coli* cells (green), and MG1655 Δ*pts E. coli* cells (purple) were grown in LB medium containing 25 mM glucose, and glucose consumption measurements were performed as described in Materials and Methods in the presence of 1 mM glucose. Download
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Figure S4, TIF file, 0.1 MB
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Localization of DivIVA-GFP and EI-mCherry in *E. coli* Δpts cells. Images showing the distribution pattern of *B. subtilis* DivIVA protein fused with GFP (top) and of overexpressed *E. coli* EI protein fused to mCherry (bottom) in *E. coli* Δpts cells. The cells were observed with DIC (gray), and the GFP fusion protein (green) or mCherry fusion protein (red) were observed by fluorescence microscopy. Download
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Figure S5, TIF file, 0.2 MB

###### 

Complementation of a *ptsI E. coli* mutant with the *B. subtilis* EI protein. *E. coli ptsI19*^*ts*^ cells (A) and *ptsI19*^*ts*^ cells containing either pBADLLEI-mCherry, which expresses the *E. coli* EI protein fused to mCherry (B), or pGSbsEI-GFP, which expresses the *B. subtilis* EI protein fused to GFP (C), were streaked on a MacConkey plate containing 1% mannitol and 1 mM IPTG and incubated overnight at the restrictive temperature (42°C). Download
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Figure S6, TIF file, 0.4 MB
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Bacterial strains used in this study and their relevant phenotype.
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Table S1, DOC file, 0.1 MB.
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Plasmids used in this study and the proteins they encode.
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Table S2, DOC file, 0.1 MB.
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